Christer Ahlberg interviewed by Redeye about the Q2 report and HEEALING1
Cinclus Pharma CEO Christer Ahlberg discusses the Q2 2026 Interim Report and provides an update on the Phase III HEEALING1 trial in an interview with Redeye.
Read more
In the spotlight
Check out the latest updates from Cinclus Pharma
Watch the full presentation from Jefferies Global Healthcare Conference
CEO Christer Ahlberg presents the company and the drug candidate, linaprazan glurate.
Read more
Cinclus Pharma is proud to be the Gold Sponsor of the OESO-SEMPIRE World Conference in Esophagology
This international congress brings together leading experts, researchers and healthcare professionals from around the world to share knowledge, discuss the latest advances in esophagology, and shape the future of esophageal care and treatment.
Read more